版本:
中国

BRIEF-VBI Vaccines completes pre-IND meeting for its Glioblastoma Immunotherapy Candidate

Oct 11 VBI Vaccines Inc

* VBI Vaccines completes pre-ind meeting for its glioblastoma immunotherapy candidate

* VBI Vaccines Inc - VBI anticipates filing ind for VBI-1901 in first half of 2017

* VBI Vaccines Inc - FDA will consider a fast track designation for VBI-1901 at time of IND submission Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐